Sbp2l contributes to oligodendrocyte maturation through translational control in Tcf7l2 signaling
Open Access
- 16 November 2023
- Vol. 26 (12) , 108451
Abstract
No abstract availableKeywords
Funding Information
- Naito Foundation
- Takeda Pharmaceutical Company
- Japan Society for the Promotion of Science (JP19H03543, JP19K07345, JP20H00485a, JP22H05589, JP22K06879)
- Ministry of Education, Culture, Sports, Science and Technology
- Core Research for Evolutional Science and Technology (JP23gm1710010)
This publication has 62 references indexed in Scilit:
- Glycolytic oligodendrocytes maintain myelin and long-term axonal integrityNature, 2012
- Insights into the regulation of protein abundance from proteomic and transcriptomic analysesNature Reviews Genetics, 2012
- PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2Nature Neuroscience, 2012
- Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 SignalingNeuron, 2010
- Analytical approaches to RNA profiling data for the identification of genes enriched in specific cellsNucleic Acids Research, 2010
- Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing FactorsJournal of Biological Chemistry, 2009
- HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interactionNature Neuroscience, 2009
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesNature Genetics, 2006
- A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAsThe EMBO Journal, 2000
- Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor systemNeuron, 1993